Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 Diabetics
Completed · Phase 2/Phase 3
Conditions studied: Diabetes Mellitus, Type 2
In brief
To compare the postprandial glycemic and insulinemic response of subjects with type 2 diabetes consuming a typical breakfast meal or no breakfast to 10004RF via a meal tolerance test (MTT).
Key facts
- Study ID
- NCT01324921
- Run by
- Abbott Nutrition
- People needed
- 37
- Starts
- 2010-08-01
- Expected to finish
- 2010-09-01
- Last updated by the study team
- 2011-03-30
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- type 2 diabetes
- between 21 and 75 years of age
- male or a non-pregnant, non-lactating female, at least 6 weeks postpartum or postmenopausal or surgically sterile
- BMI is > 18.5 kg/m2 and <35 kg/m2
- If subject is on a chronic medication such as an anti-hypertensive, lipid-lowering, thyroid medication or hormone therapy, they have been on constant dosage for at least two months prior to screening visit.
You may not qualify if…
- Hemoglobin A1c value at screening of greater than or equal to 9%.
- Uses exogenous insulin or exenatide for glucose control.
- type 1 diabetes.
- history of diabetic ketoacidosis.
- current infection; has had inpatient surgery, or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks prior to screening visit.
- active malignancy
- significant cardiovascular event ≤ six months prior to screening visit; or stated history of congestive heart failure.
- end-stage organ failure or is status post organ transplant.
- history of renal disease.
- current hepatic disease.
- history of severe gastroparesis.
- chronic, contagious, infectious disease
- taking any herbals, dietary supplements, or medications, other than anti-hyperglycemic medications, that could profoundly affect blood glucose.
- clotting or bleeding disorders
- allergic or intolerant to any ingredient found in the study products.
- habitual user of tobacco products (
Where it is running
- Provident Clinical Research and Consulting LLC — Glen Ellyn, Illinois, United States
- Radiant Research — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.